Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rausch

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
The Lancet. Infectious Diseases|November 21, 2021
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trialMahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.
The Lancet. Infectious Diseases|July 27, 2023
Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trialIssaka Sagara, Sara A Healy, Mahamadoun H Assadou, et al.
Nature|November 13, 2024
NK2R control of energy expenditure and feeding to treat metabolic diseasesFrederike Sass, Tao Ma, Jeppe H Ekberg, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
The Lancet. Infectious Diseases|November 21, 2021
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trialMahamadou S Sissoko, Sara A Healy, Abdoulaye Katile, et al.
Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.
The Lancet. Infectious Diseases|July 27, 2023
Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trialIssaka Sagara, Sara A Healy, Mahamadoun H Assadou, et al.
Nature|November 13, 2024
NK2R control of energy expenditure and feeding to treat metabolic diseasesFrederike Sass, Tao Ma, Jeppe H Ekberg, et al.
Pageof 18